Geometric Surrogates for Clinical Management of Abdominal Aortic Aneurysms
腹主动脉瘤临床治疗的几何替代物
基本信息
- 批准号:8888896
- 负责人:
- 金额:$ 51.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:Abdominal Aortic AneurysmAddressAneurysmAwardBiomechanicsBlood VesselsCaliberCharacteristicsClassificationClinicClinicalClinical ManagementClinical ResearchComplexConsentDataDevelopmentDiagnosisDiseaseElectrocardiogramElementsFoundationsGeometryGoalsGrowthImageImaging TechniquesIndividualKnowledgeLearningMachine LearningMagnetic Resonance ImagingMeasuresMechanicsMethodsModelingMotionOperative Surgical ProceduresOutcomeOutcomes ResearchPatientsPhasePhysiologicalPropertyRecordsRecruitment ActivityResearchRiskRuptureRuptured Abdominal Aortic AneurysmRuptured AneurysmSpatial DistributionStagingStressSurgeonSurveillance ProgramSurvival RateTechnologyTestingTimeValidationX-Ray Computed Tomographybaseclinically significantcomputerized toolsdesignhigh riskimprovedindexinginnovationnovelpressureprimary outcomeprospectivepublic health relevanceradiologistrepairedsoft tissuestandard of caretool
项目摘要
DESCRIPTION (provided by applicant): This proposal will investigate the following hypothesis: that the quantification of geometric surrogates, which predict the ensuing peak wall rupture risk index (PWRRI), will provide an improved estimate of aneurysm rupture risk compared to the clinical standard of maximum aneurysm diameter. We thus propose the highly innovative use of both radiological and non-radiological clinical imaging to develop a computational tool that can assess AAA risk of rupture with greater accuracy than the current clinical standard. Such a tool will allow the accurate quantification of individual AAA geometry to
achieve the main goal of the study, which is to identify the patient-specific AAA geometry characteristics that are surrogates for patient-specific PWRRI. In the proposed approach, we will first compute a truly individualized PWRRI based on an innovative method called image-based Vascular Mechanical Characterization technology (iV-MeCh). The geometry characteristics highly correlated with PWRRI will be considered the surrogates of this biomechanics-based index. A second phase of the study will be the validation of the surrogates with actual clinical outcomes, which will yield the accurate predictors of rupture. This approach, devoid of complex finite element modeling and based on a fast, nearly automated computational tool for geometry quantification, would provide an exceptional rationale for the need for surgical intervention and be of major clinical significance. Therefore, the following specific aims are to be completed during the project period to address the aforementioned hypothesis: (1) Validate iV-MeCh for estimating patient-specific spatio-temporal AAA wall stress; (2) Calculate individual PWRRI using iV-MeCh for high and low risk of rupture AAA; (3) Identify the individual geometry characteristics that are surrogates of PWRRI; and (4) Assess the clinical significance of geometric surrogates for the prediction of AAA rupture risk. The primary outcome of this research will be the ability to disambiguate or demystify rupture risk in AAA for which the standard of care (maximum diameter) is not an accurate metric for assessing their at-risk condition. The geometric surrogates of PWRRI are hypothesized to reduce false positives and false negatives compared to the conventional maximum diameter cut-off for recommending elective repair. In addition, PWRRI is predicted by means of a new, novel technique (iV-MeCh), which estimates wall stress in aneurysms by means of non-radiological clinical imaging and without the use of constitutive soft tissue mechanics.
描述(由申请人提供):本提案将研究以下假设:与最大动脉瘤直径的临床标准相比,预测随后的峰值壁破裂风险指数(PWRRI)的几何替代物的量化将提供动脉瘤破裂风险的改进估计。因此,我们建议高度创新地使用放射学和非放射学临床成像来开发一种计算工具,该工具可以比当前临床标准更准确地评估AAA破裂风险。这种工具将允许准确量化单个AAA几何结构,
实现本研究的主要目标,即识别作为患者特异性PWRRI替代物的患者特异性AAA几何结构特征。在所提出的方法中,我们将首先计算一个真正个性化的PWRRI的基础上的创新方法称为基于图像的血管力学表征技术(iV-MeCh)。与PWRRI高度相关的几何特征将被视为该基于生物力学的指数的替代物。研究的第二阶段将是用实际临床结果验证替代物,这将产生破裂的准确预测因子。这种方法,没有复杂的有限元建模,并基于一个快速的,几乎自动化的几何量化计算工具,将提供一个特殊的理由,需要手术干预,并具有重大的临床意义。因此,在项目期间将完成以下具体目标,以解决上述假设:(1)用于估计患者特定时空AAA壁应力的iV-MeCh;(2)使用iV-MeCh计算高和低破裂AAA风险的个体PWRRI;(3)识别作为PWRRI替代品的个体几何特征;和(4)评估几何替代物对预测AAA破裂风险的临床意义。本研究的主要结果是能够消除或揭开AAA破裂风险的神秘面纱,因为标准治疗(最大直径)不是评估其风险状况的准确指标。与推荐择期修复的传统最大直径截止值相比,PWRRI的几何替代物被假设为减少假阳性和假阴性。此外,PWRRI是通过一种新的、新颖的技术(iV-MeCh)来预测的,该技术通过非放射性临床成像来估计动脉瘤中的壁应力,而不使用构成性软组织力学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ENDER A FINOL其他文献
ENDER A FINOL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ENDER A FINOL', 18)}}的其他基金
A NONLINEAR MEMBRANE BASED ANALYSIS FOR ESTIMATING THE RUPTURE POTENTIAL OF ABDOMINAL AORTIC ANEURYSMS
基于非线性膜的分析估计腹主动脉瘤的破裂可能性
- 批准号:
10280976 - 财政年份:2021
- 资助金额:
$ 51.44万 - 项目类别:
A NONLINEAR MEMBRANE BASED ANALYSIS FOR ESTIMATING THE RUPTURE POTENTIAL OF ABDOMINAL AORTIC ANEURYSMS
基于非线性膜的分析估计腹主动脉瘤的破裂可能性
- 批准号:
10696243 - 财政年份:2021
- 资助金额:
$ 51.44万 - 项目类别:
A NONLINEAR MEMBRANE BASED ANALYSIS FOR ESTIMATING THE RUPTURE POTENTIAL OF ABDOMINAL AORTIC ANEURYSMS
基于非线性膜的分析估计腹主动脉瘤的破裂可能性
- 批准号:
10478276 - 财政年份:2021
- 资助金额:
$ 51.44万 - 项目类别:
Geometric Surrogates for Clinical Management of Abdominal Aortic Aneurysms
腹主动脉瘤临床治疗的几何替代物
- 批准号:
9463479 - 财政年份:2015
- 资助金额:
$ 51.44万 - 项目类别:
A Fluid-Structure Interaction Method for Patient-Specific Cardiovascular Modeling
用于患者特定心血管建模的流固耦合方法
- 批准号:
7885996 - 财政年份:2009
- 资助金额:
$ 51.44万 - 项目类别:
A Fluid-Structure Interaction Method for Patient-Specific Cardiovascular Modeling
用于患者特定心血管建模的流固耦合方法
- 批准号:
7661248 - 财政年份:2009
- 资助金额:
$ 51.44万 - 项目类别:
A Fluid-Structure Interaction Method for Patient-Specific Cardiovascular Modeling
用于患者特定心血管建模的流固耦合方法
- 批准号:
8115487 - 财政年份:2009
- 资助金额:
$ 51.44万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 51.44万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 51.44万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 51.44万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 51.44万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 51.44万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 51.44万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 51.44万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 51.44万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 51.44万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 51.44万 - 项目类别:
Research Grant